No Prescription |
 |
 | ||
|
Skinoren Azelex |
|
| ||
No Prescription » Prescription Drugs 15 » Skinoren Azelex Azelaic acid gel is used to clear the bumps lesions and swelling caused by rosacea (a skin disease that causes redness flushing and pimples on the face). Azelaic acid cream is used to treat acne. Azelaic acid is in a class of medications called dicarboxylic acids. It works to treat acne by killing the bacteria that infect pores and by decreasing production of keratin a natural substance that can lead to the development of acne. The way azelaic acid works to treat rosacea is not known.It is usually applied twice a day in the morning and the evening. To help you remember to use azelaic acid use it at around the same times every day. Buy Skinoren Azelex and other Prescription Drugs 15 products online at Medstore. Buy Online at Medstore - Click Here!
About Skinoren Azelex: Product Type: Prescription Drugs 15 Skinoren ( Azelex Finacea Generic Azelaic acid ) Skinoren (Azelex Finacea Generic Azelaic acid) Azelex Finacea Generic Azelaic acid n/a Azelex Finacea Generic Azelaic acid Skinoren
View more Prescription Drugs 15 No Prescription: NEW YORK, Oct. 5, 2011 /PRNewswire via COMTEX/ -- Reportlinker.com announces that a new market research report is available in its catalogue: European Pharmaceutical Market: Strategic Assessments of Leading Suppliers http://www.reportlinker.com/p0651431/European-Pharmaceutical-Market-Strategic-Assessments-of-Leading-Suppliers.html #utm_source=prnewswire&utm_medium=pr&utm_campaign=Drug_and_Medication This report provides industry executives with strategically significant competitor information and analysis of the leading players in the European pharmaceutical market. The report provides a worldwide strategic overview of the pharmaceutical market, including: Sales forecast for major product segments: ethical, OTC, generics. Sales forecast for major drug categories: cardiovascular, gastrointestinal, antibiotic, CNS, respiratory, musculoskeletal, hormonal/genitourinary, dermatological, oncological, ophthalmic, and others. In addition, the report reviews major regulatory, technological, economic, demographic, and social trends with potentially significant impact on the market during the next five years, including discussion of such key issues as pricing, industry consolidation, market globalization, growing R&D cost, generics, as well as advances in genomics, proteomics, drug screening, tissue engineering, bioinformatics, and other technologies. The companies analyzed in this report include Abbott, AstraZeneca, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Johnson & Johnson, Merck, Novartis, Pfizer, Roche, Sanofi-Aventis and Wyeth.
| ||
